X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (76) 76
erk-1/2 (71) 71
animals (46) 46
humans (41) 41
biochemistry & molecular biology (25) 25
cell biology (24) 24
mice (24) 24
expression (20) 20
mitogen-activated protein kinase 1 - metabolism (20) 20
phosphorylation (20) 20
cell line, tumor (19) 19
male (18) 18
mitogen-activated protein kinases - metabolism (18) 18
oncology (18) 18
rats (17) 17
apoptosis (14) 14
akt (13) 13
activation (12) 12
blotting, western (12) 12
mitogen-activated protein kinase 3 - metabolism (12) 12
cells, cultured (11) 11
erk-1 (11) 11
female (11) 11
physiological aspects (11) 11
research (11) 11
cancer (10) 10
erk-1/-2 (10) 10
inhibition (10) 10
map kinase signaling system (10) 10
medicine, research & experimental (10) 10
mitogen-activated protein kinase 3 (10) 10
proliferation (10) 10
signal transduction (10) 10
vessel dilator (10) 10
atrial-natriuretic-peptide (9) 9
biophysics (9) 9
cells (9) 9
enzyme inhibitors - pharmacology (9) 9
extracellular signal-regulated map kinases - metabolism (9) 9
nf-kappa-b (9) 9
p38 mitogen-activated protein kinases - metabolism (9) 9
receptors (9) 9
erk‐1/2 (8) 8
inflammation (8) 8
map kinase (8) 8
map kinase signaling system - drug effects (8) 8
natriuretic peptides (8) 8
ras (8) 8
receptor (8) 8
signal transduction - drug effects (8) 8
activated protein-kinase (7) 7
cell line (7) 7
cell proliferation - drug effects (7) 7
cell survival - drug effects (7) 7
enzyme activation (7) 7
gene expression (7) 7
growth-factor (7) 7
in-vitro (7) 7
metastasis (7) 7
migration (7) 7
signaling pathway (7) 7
tumor cells, cultured (7) 7
2 (6) 6
adenocarcinoma - pathology (6) 6
atrial natriuretic factor - pharmacology (6) 6
cytokines (6) 6
differentiation (6) 6
dose-response relationship, drug (6) 6
gene (6) 6
gene-expression (6) 6
hematology (6) 6
in-vivo (6) 6
invasion (6) 6
kinase (6) 6
kinases (6) 6
macrophages (6) 6
mice, nude (6) 6
mitogen-activated protein kinase 1 - antagonists & inhibitors (6) 6
nf-kappa b - metabolism (6) 6
p38 (6) 6
phosphorylation - drug effects (6) 6
prostate-cancer cells (6) 6
protein (6) 6
rats, sprague-dawley (6) 6
signal transduction - physiology (6) 6
time factors (6) 6
analysis (5) 5
cardiac hormones (5) 5
endocrinology & metabolism (5) 5
growth (5) 5
inhibit mek-1/2 activation (5) 5
mice, inbred c57bl (5) 5
neurosciences (5) 5
pancreatic neoplasms - drug therapy (5) 5
pathway (5) 5
pharmacology & pharmacy (5) 5
proteins (5) 5
proto-oncogene proteins c-akt - metabolism (5) 5
rabbits (5) 5
up-regulation (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Experimental Metastasis, ISSN 0262-0898, 06/2012, Volume 29, Issue 5, pp. 471 - 492
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 10/2015, Volume 135, Issue 2, pp. 309 - 322
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2012, Volume 165, Issue 6, pp. 1773 - 1788
Journal Article
International Journal of Biochemistry and Cell Biology, ISSN 1357-2725, 07/2017, Volume 88, pp. 100 - 112
Journal Article
The EMBO Journal, ISSN 0261-4189, 12/2001, Volume 20, Issue 24, pp. 7108 - 7116
Journal Article
Brain Research, ISSN 0006-8993, 12/2017, Volume 1677, pp. 118 - 128
Stroke commonly leads to adult disability and death worldwide. Its major symptoms are spastic hemiplegia and discordant motion, consequent to neuronal cell... 
Glial fibrillary acidic protein (GFAP) | Metallopeptidase-9 (MMP-9) | Stroke | ERK-1/2 signaling pathway | Ischemia/reperfusion injury | Activated-caspase 3 | Brain-derived neurotrophic factor (BDNF) | Amyloid precursor protein (APP) | (−)-Phenserine | Middle cerebral artery occlusion (MCAO) | B-cell lymphoma 2 (Bcl-2) expression | TISSUE-PLASMINOGEN ACTIVATOR | ALZHEIMERS-DISEASE | FOCAL CEREBRAL-ISCHEMIA | AMYLOID PRECURSOR PROTEIN | NEUROSCIENCES | MATRIX METALLOPROTEINASES | MESSENGER-RNA | (-)-Phenserine | MATRIX-METALLOPROTEINASE-9 GENE | BRAIN-BARRIER DISRUPTION | STEM-CELL THERAPY | TRANSGENIC MICE | Neurons - pathology | Cell Hypoxia - physiology | Apoptosis - drug effects | Humans | Reperfusion Injury - drug therapy | Brain Ischemia - metabolism | Male | Dose-Response Relationship, Drug | Stroke - pathology | Neuroprotective Agents - pharmacology | Neurons - metabolism | Neurons - drug effects | Reperfusion Injury - metabolism | Cell Survival - physiology | Cell Survival - drug effects | Cell Hypoxia - drug effects | Physostigmine - analogs & derivatives | Reperfusion Injury - pathology | Rats | Stroke - drug therapy | Rats, Sprague-Dawley | Physostigmine - pharmacology | Glucose - deficiency | Stroke - metabolism | Animals | Cholinesterase Inhibitors - pharmacology | Brain Ischemia - drug therapy | Brain Ischemia - pathology | Cell Line, Tumor | Apoptosis - physiology | Brain | Neurons | Analysis | Injuries | Apoptosis | Stroke (Disease) | Amyloid beta-protein | Lymphomas | Index Medicus | middle cerebral artery occlusion (MCAO) | brain-derived neurotrophic factor (BDNF) | metallopeptidase-9 (MMP-9) | activated-caspase 3 | reperfusion injury | stroke | amyloid precursor protein (APP) | glial fibrillary acidic protein (GFAP) | ischemia | ERK-1 | 2 signaling pathway
Journal Article